BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7228964)

  • 1. The separation and determination of liothyronine and levothyroxine in tablets by reversed-phase high performance liquid chromatography.
    Smith DJ; Biesemeyer M; Yaciw C
    J Chromatogr Sci; 1981 Feb; 19(2):72-8. PubMed ID: 7228964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity.
    Rapaka RS; Knight PW; Prasad VK
    J Pharm Sci; 1981 Feb; 70(2):131-4. PubMed ID: 7205213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse phase high pressure liquid chromatographic determination of some iodoamino acid contaminants in sodium liothyronine or sodium levothyroxine.
    Smith DJ; Graham JH
    J Assoc Off Anal Chem; 1979 Jul; 62(4):818-21. PubMed ID: 500533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of liothyronine and levothyroxine in thyroid preparations by liquid chromatography.
    Richheimer SL; Jensen CB
    J Pharm Sci; 1986 Feb; 75(2):215-7. PubMed ID: 3514844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The separation and determination of chlorpromazine and some of its related compounds by reversed-phase high performance liquid chromatography.
    Smith DJ
    J Chromatogr Sci; 1981 Feb; 19(2):65-71. PubMed ID: 7228963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
    Richheimer SL; Amer TM
    J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of sodium levothyroxine in bulk, tablet, and injection formulations by high-performance liquid chromatography.
    Brower JF; Toler DY; Reepmeyer JC
    J Pharm Sci; 1984 Sep; 73(9):1315-7. PubMed ID: 6491963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.
    Garnick RL; Burt GF; Long DA; Bastian JW; Aldred JP
    J Pharm Sci; 1984 Jan; 73(1):75-7. PubMed ID: 6694088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of sodium levothyroxine or sodium liothyronine in tablets.
    Graham JH; Banes D; Biesemeyer ME; Nadkarni A
    J Pharm Sci; 1974 May; 63(5):763-6. PubMed ID: 4830000
    [No Abstract]   [Full Text] [Related]  

  • 10. High-pressure liquid chromatography of amino acids, peptides and proteins. V. Separation of thyroidal iodo-amino acids by hydrophilic ion-paired reversed-phase high-performance liquid chromatography.
    Hearn MT; Hancock WS; Bishop CA
    J Chromatogr; 1978 Sep; 157():337-44. PubMed ID: 701445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pulse polarographic analysis of thyroid hormone: determination of iodine, thyroxine, and liothyronine.
    Holak W; Shostak D
    J Pharm Sci; 1979 Mar; 68(3):338-42. PubMed ID: 423124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.
    Collier JW; Shah RB; Bryant AR; Habib MJ; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2011 Feb; 54(3):433-8. PubMed ID: 20947276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impurity profiling of liothyronine sodium by means of reversed phase HPLC, high resolution mass spectrometry, on-line H/D exchange and UV/Vis absorption.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Sep; 143():147-158. PubMed ID: 28599168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets.
    El-Sherif ZA; El-Zeany B; El-Houssini OM
    J Pharm Biomed Anal; 2005 Jan; 36(5):975-81. PubMed ID: 15620522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of dienestrol and its dosage forms by high-performance liquid chromatography.
    Bailey LC; Bailey CA
    J Pharm Sci; 1979 Apr; 68(4):508-10. PubMed ID: 438981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of chlorthalidone and clonidine hydrochloride in tablets by HPLC.
    Walters SM; Stonys DB
    J Chromatogr Sci; 1983 Jan; 21(1):43-5. PubMed ID: 6833444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liothyronine and levothyroxine in Armour thyroid.
    Blumberg KR; Mayer WJ; Parikh DK; Schnell LA
    J Pharm Sci; 1987 Apr; 76(4):346-7. PubMed ID: 3598896
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of rosiglitazone in coated tablets by MEKC and HPLC methods.
    Gomes P; Sippel J; Jablonski A; Steppe M
    J Pharm Biomed Anal; 2004 Nov; 36(4):909-13. PubMed ID: 15533689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid analysis for iodotyrosines and iodothyronines in thyroglobulin by reversed-phase liquid chromatography.
    Alexander NM; Nishimoto M
    Clin Chem; 1979 Oct; 25(10):1757-60. PubMed ID: 476925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ion-pair RP-HPLC method for determination of five components in compound α-ketoacid tablets.
    Zhang D; Zhang P; Jiang Q; Kong Y; Zhu M; Zhang T
    J Pharm Biomed Anal; 2012 Jul; 66():387-91. PubMed ID: 22510314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.